Gene · 6370
Papers1,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developing neural network diagnostic models and potential drugs based on novel identified immune-related biomarkers for celiac disease. | Hum Genomics | 2023 | 37587523 | PubTator, text mining | PubMed |
| Current Therapeutics in Primary Sclerosing Cholangitis. | J Clin Transl Hepatol | 2023 | 37577219 | PubTator, text mining | PubMed |
| Targeted Application of Functional Foods as Immune Fitness Boosters in the Defense against Viral Infection. | Nutrients | 2023 | 37571308 | PubTator, text mining | PubMed |
| Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain. | Molecules | 2023 | 37570736 | PubTator, text mining | PubMed |
| CCR9/CXCR5 Co-Expressing CD4 T Cells Are Increased in Primary Sjögren's Syndrome and Are Enriched in PD-1/ICOS-Expressing Effector T Cells. | Int J Mol Sci | 2023 | 37569326 | PubTator, text mining | PubMed |
| Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk. | Hepatol Commun | 2023 | 37555943 | PubTator, text mining | PubMed |
| Differences in the inflammatory proteome of East African and Western European adults and associations with environmental and dietary factors. | Elife | 2023 | 37555575 | PubTator, text mining | PubMed |
| GWAS reveals genetic basis of a predisposition to severe COVID-19 through in silico modeling of the FYCO1 protein. | Front Med (Lausanne) | 2023 | 37547597 | PubTator, text mining | PubMed |
| Ruan Jian Qing Mai's Formula Promotes Bone Marrow-Derived Mesenchymal Stem Cell Migration and Proliferation. | Altern Ther Health Med | 2023 | 37535926 | PubTator, text mining | PubMed |
| An immuno-lipidomic signature revealed by metabolomic and machine-learning approaches in labial salivary gland to diagnose primary Sjögren's syndrome. | Front Immunol | 2023 | 37520535 | PubTator, text mining | PubMed |
| Host Cell Response to Rotavirus Infection with Emphasis on Virus-Glycan Interactions, Cholesterol Metabolism, and Innate Immunity. | Viruses | 2023 | 37515094 | PubTator, text mining | PubMed |
| The Potential of Probiotics as Ingestible Adjuvants and Immune Modulators for Antiviral Immunity and Management of SARS-CoV-2 Infection and COVID-19. | Pathogens | 2023 | 37513775 | PubTator, text mining | PubMed |
| From Teeth to Therapy: A Review of Therapeutic Potential within the Secretome of Stem Cells from Human Exfoliated Deciduous Teeth. | Int J Mol Sci | 2023 | 37511524 | PubTator, text mining | PubMed |
| Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination. | EBioMedicine | 2023 | 37506557 | PubTator, text mining | PubMed |
| Insight on immune cells in rejection and infection postlung transplant. | Immun Inflamm Dis | 2023 | 37506156 | PubTator, text mining | PubMed |
| A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma. | Int J Med Sci | 2023 | 37484803 | PubTator, text mining | PubMed |
| Food-sensitized pediatric patients show colonic cow's milk protein-specific Th2 cells. | J Leukoc Biol | 2023 | 37478370 | PubTator, text mining | PubMed |
| The application of Aptamer in biomarker discovery. | Biomark Res | 2023 | 37468977 | PubTator, text mining | PubMed |
| Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis. | Exp Mol Med | 2023 | 37464092 | PubTator, text mining | PubMed |
| An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer. | Adv Ther | 2023 | 37462865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6370/papers?page=12